Definitive Contract 75D30118C02908
Award Date 9/10/18
Potential Completion Date 2/29/20
Potential Value $157K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Columbus, OH 43210, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order for $248,948.00 to The Ohio State University to provide scientific services related to Salmonella research. The contract, which has a completion date of September 29, 2022, was awarded on September 30, 2020 and does not have a set-aside designation. The Ohio State University, as a public research university, has extensive experience conducting scientific research and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $155,333.00 definitive contract to The Ohio State University to conduct a study on antibiotic stewardship under a Broad Agency Announcement (BAA). The contract is a cost-no-fee arrangement with a completion date of February 29, 2020. The Ohio State University, a public research university, has experience conducting a variety of federally funded research and support services for agencies such as the...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $234,400.00 firm fixed price purchase order to The Ohio State University for the testing of gnotobiotic piglets. The contract has a completion date of December 31, 2022 and was awarded on July 23, 2020. The Ohio State University is a public research university that has a history of providing various goods and services to federal agencies through prime contracts and subcontracts, including...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to The Ohio State University to study and test a heptavalent combination vaccine in gnotobiotic piglets. The $249,717.00 contract has an August 21, 2021 completion date and was awarded on August 22, 2019. The Ohio State University is a public research university that has extensive experience conducting research and providing services to federal agencies through both...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $693,598.00 to The Ohio State University (OSU) on September 29, 2017. The contract, which does not have a set-aside designation, is for unspecified "other functions" and is scheduled for completion on March 31, 2019. OSU, through its Office of Sponsored Programs, has previously provided various goods and services to federal agencies,...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $963,253.00 firm fixed price purchase order contract to The Ohio State University for research on "Foodborne Pathogens in Small Specialty Farming Produce and Transduction of Antimicrobial Resistance Genes in Agricultural Systems." The contract, which does not have a set-aside designation, runs through September 29, 2024. As a public research university, The Ohio State University has a history...
- This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Ohio State University in the amount of $630,103.00. The contract has a firm fixed price pricing type and a completion date of April 30, 2023. It was awarded on August 1, 2020 and does not have a set-aside designation. The contract is for FY20 BAA TOPIC 5.5 and the place of performance is Chamblee, Georgia. The Ohio State University is a public research university...
- This is a $473,312 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University to prevent the dissemination of carbapenem-resistant Enterobacteriaceae (CRE). The contract has a period of performance from September 15, 2016 to September 29, 2017 and is a cost-no-fee contract. The Ohio State University has previously received other federal contract awards and grants, including work for the National Institutes of Health, NASA, the Drug...
- This is a federal contract award from the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to The Ohio State University (OSU) for a study on small specialty farming produce. The contract is a firm-fixed-price purchase order with a potential value of $110,600.00. The contract was awarded on September 11, 2017 and the period of performance is through September 14, 2018. The contract does not have a set-aside designation. As a public research university, OSU has...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University (OSU) for the testing of parenterally administered live attenuated rotavirus, with a completion date of September 5, 2025 and a ceiling value of $248,005.00. The contract does not have a set-aside designation. OSU is a public research university that has a history of providing various goods and services to federal agencies, including coordination and support...